Integrating EyeCare

• April 20, 2026

Optimizing MIGS for Practice and Center Success

The key is execution, understanding the clinical landscape, controlling device cost, engineering the intraoperative workflow, and scheduling/staffing with intention.

• by Mitchell C. Shultz, MD

• July 1, 2026

• 9 min

Do Systemic Alpha-2 Agonists Lower Glaucoma Risk?

A large US cohort study found systemic alpha-2 agonist use was associated with a lower hazard of glaucoma-related diagnoses vs. beta-blockers.

• by Andrea Surnit

• July 8, 2026

• 3 min

Optical coherence tomography acquisition efficiency: comparison of Heidelberg spectralis OCT2 module & Zeiss Cirrus HD-OCT model 6000

• by Charissa H. Tan, Michael S. Jensen, Shannon Fitch, Richard Ordonez, Abigail Jacketta, Jeff Courtright, Jonathan Shepherd, Mathew Vierkant, Paul Crown, Ben J. Brintz, Susan Chortkoff, Brian C. Stagg

• July 20, 2026